Although a combination of a platinum-based agent and a fluorouracil-based agent is regarded as an acceptable first-line chemotherapy regimen for patients with HER2-negative AGC in the sixth edition of the Japanese Gastric Cancer Treatment Guidelines, the optimal regimen for older patients has not been fully elucidated [2]. Here, ERBB2 is linked to gastric cancer.